chr11-112252374-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145024.1(PLET1):āc.422T>Cā(p.Leu141Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000825 in 1,551,462 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001145024.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLET1 | NM_001145024.1 | c.422T>C | p.Leu141Pro | missense_variant | 3/4 | ENST00000338832.4 | NP_001138496.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLET1 | ENST00000338832.4 | c.422T>C | p.Leu141Pro | missense_variant | 3/4 | 5 | NM_001145024.1 | ENSP00000341412.2 | ||
PTS | ENST00000531673.5 | n.*363+14868A>G | intron_variant | 1 | ENSP00000433469.1 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000963 AC: 15AN: 155838Hom.: 0 AF XY: 0.0000726 AC XY: 6AN XY: 82594
GnomAD4 exome AF: 0.0000522 AC: 73AN: 1399148Hom.: 0 Cov.: 33 AF XY: 0.0000420 AC XY: 29AN XY: 690100
GnomAD4 genome AF: 0.000361 AC: 55AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.000376 AC XY: 28AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2024 | The c.422T>C (p.L141P) alteration is located in exon 3 (coding exon 3) of the PLET1 gene. This alteration results from a T to C substitution at nucleotide position 422, causing the leucine (L) at amino acid position 141 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at